Based on network pharmacology and molecular docking, this study revealed the key targets of Rk1+Rg5 intervention in T2DM, as well as the main signaling pathways (the insulin resistance signaling pathway, cAMP signaling pathway, PPAR signaling pathway, and p53 signaling pathway). Here, TP53 is linked to type 2 diabetes mellitus.